Concepts (163)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Breast Neoplasms | 46 | 2021 | 1536 | 9.060 |
Why?
|
| Mammography | 28 | 2021 | 310 | 8.050 |
Why?
|
| Breast | 14 | 2020 | 137 | 2.860 |
Why?
|
| Early Detection of Cancer | 17 | 2021 | 454 | 2.770 |
Why?
|
| Mass Screening | 10 | 2020 | 843 | 2.020 |
Why?
|
| Magnetic Resonance Imaging | 10 | 2020 | 2223 | 1.970 |
Why?
|
| Lymph Node Excision | 3 | 2019 | 91 | 1.370 |
Why?
|
| Continuity of Patient Care | 3 | 2019 | 170 | 1.260 |
Why?
|
| Lymph Nodes | 3 | 2020 | 258 | 1.070 |
Why?
|
| Workload | 2 | 2016 | 103 | 1.000 |
Why?
|
| Female | 47 | 2021 | 38074 | 1.000 |
Why?
|
| Radiologists | 3 | 2019 | 35 | 0.920 |
Why?
|
| Comprehension | 3 | 2020 | 71 | 0.860 |
Why?
|
| Breast Density | 2 | 2019 | 21 | 0.840 |
Why?
|
| Efficiency, Organizational | 2 | 2019 | 61 | 0.760 |
Why?
|
| Humans | 49 | 2021 | 68618 | 0.750 |
Why?
|
| Diagnostic Imaging | 2 | 2019 | 201 | 0.720 |
Why?
|
| Middle Aged | 22 | 2020 | 21147 | 0.710 |
Why?
|
| Biopsy | 6 | 2020 | 540 | 0.700 |
Why?
|
| Correspondence as Topic | 1 | 2019 | 5 | 0.680 |
Why?
|
| Radiographic Image Interpretation, Computer-Assisted | 2 | 2019 | 373 | 0.680 |
Why?
|
| Semantics | 1 | 2019 | 37 | 0.670 |
Why?
|
| Lymphatic Diseases | 1 | 2019 | 27 | 0.660 |
Why?
|
| Carcinoma | 1 | 2020 | 215 | 0.640 |
Why?
|
| Multimodal Imaging | 2 | 2016 | 62 | 0.630 |
Why?
|
| Workflow | 1 | 2019 | 100 | 0.630 |
Why?
|
| Waiting Lists | 1 | 2019 | 104 | 0.630 |
Why?
|
| Intraoperative Care | 1 | 2018 | 91 | 0.610 |
Why?
|
| Insurance Coverage | 1 | 2018 | 99 | 0.600 |
Why?
|
| Aged, 80 and over | 13 | 2019 | 4848 | 0.550 |
Why?
|
| Patient Satisfaction | 1 | 2019 | 378 | 0.540 |
Why?
|
| Aged | 16 | 2020 | 14862 | 0.510 |
Why?
|
| Adult | 17 | 2020 | 21403 | 0.510 |
Why?
|
| Sensitivity and Specificity | 6 | 2017 | 1753 | 0.480 |
Why?
|
| Health Knowledge, Attitudes, Practice | 2 | 2019 | 767 | 0.450 |
Why?
|
| Ultrasonography | 4 | 2019 | 453 | 0.450 |
Why?
|
| Delivery of Health Care | 2 | 2014 | 445 | 0.440 |
Why?
|
| Retrospective Studies | 13 | 2020 | 7277 | 0.430 |
Why?
|
| Cost of Illness | 1 | 2014 | 206 | 0.420 |
Why?
|
| Algorithms | 3 | 2019 | 1196 | 0.400 |
Why?
|
| Carcinoma, Non-Small-Cell Lung | 1 | 2015 | 300 | 0.390 |
Why?
|
| Patient Acceptance of Health Care | 1 | 2015 | 468 | 0.380 |
Why?
|
| Axilla | 2 | 2019 | 36 | 0.330 |
Why?
|
| Image Interpretation, Computer-Assisted | 3 | 2018 | 237 | 0.300 |
Why?
|
| Predictive Value of Tests | 4 | 2018 | 1465 | 0.300 |
Why?
|
| Diagnosis, Differential | 4 | 2019 | 1140 | 0.290 |
Why?
|
| Ultrasonography, Mammary | 2 | 2018 | 39 | 0.290 |
Why?
|
| Academic Medical Centers | 2 | 2019 | 281 | 0.280 |
Why?
|
| Patient Compliance | 2 | 2020 | 402 | 0.270 |
Why?
|
| Lung Neoplasms | 1 | 2015 | 1173 | 0.260 |
Why?
|
| United States | 6 | 2018 | 7367 | 0.260 |
Why?
|
| Neoplasm Invasiveness | 3 | 2020 | 369 | 0.250 |
Why?
|
| Imaging, Three-Dimensional | 2 | 2017 | 333 | 0.240 |
Why?
|
| Neoplasm Staging | 5 | 2020 | 800 | 0.230 |
Why?
|
| Risk Factors | 4 | 2018 | 5731 | 0.220 |
Why?
|
| Young Adult | 5 | 2019 | 5717 | 0.220 |
Why?
|
| Prevalence | 2 | 2016 | 1619 | 0.200 |
Why?
|
| Image Processing, Computer-Assisted | 3 | 2019 | 689 | 0.190 |
Why?
|
| Follow-Up Studies | 7 | 2020 | 3259 | 0.190 |
Why?
|
| Reproducibility of Results | 2 | 2016 | 2077 | 0.180 |
Why?
|
| Image-Guided Biopsy | 2 | 2018 | 17 | 0.180 |
Why?
|
| Mastectomy | 1 | 2020 | 57 | 0.180 |
Why?
|
| Body Mass Index | 2 | 2019 | 867 | 0.180 |
Why?
|
| Telephone | 1 | 2020 | 160 | 0.170 |
Why?
|
| Cryosurgery | 1 | 2019 | 53 | 0.170 |
Why?
|
| Surveys and Questionnaires | 2 | 2019 | 2800 | 0.170 |
Why?
|
| Computer Systems | 1 | 2019 | 42 | 0.170 |
Why?
|
| Prognosis | 3 | 2019 | 2093 | 0.170 |
Why?
|
| Musculoskeletal Pain | 1 | 2019 | 7 | 0.170 |
Why?
|
| Carbon Dioxide | 1 | 2019 | 78 | 0.170 |
Why?
|
| False Positive Reactions | 1 | 2019 | 95 | 0.160 |
Why?
|
| Arm | 1 | 2019 | 59 | 0.160 |
Why?
|
| Sentinel Lymph Node Biopsy | 1 | 2019 | 53 | 0.160 |
Why?
|
| Age Factors | 3 | 2016 | 1864 | 0.160 |
Why?
|
| Maryland | 1 | 2018 | 77 | 0.160 |
Why?
|
| Mammary Neoplasms, Experimental | 1 | 2019 | 114 | 0.160 |
Why?
|
| Syndrome | 1 | 2019 | 255 | 0.160 |
Why?
|
| South Africa | 1 | 2018 | 45 | 0.160 |
Why?
|
| Glutamate Carboxypeptidase II | 1 | 2018 | 1 | 0.160 |
Why?
|
| Radioactive Tracers | 1 | 2018 | 5 | 0.160 |
Why?
|
| Range of Motion, Articular | 1 | 2019 | 139 | 0.160 |
Why?
|
| Communication | 2 | 2020 | 329 | 0.150 |
Why?
|
| DNA Methylation | 1 | 2019 | 193 | 0.150 |
Why?
|
| Machine Learning | 1 | 2019 | 170 | 0.150 |
Why?
|
| Artifacts | 1 | 2018 | 125 | 0.150 |
Why?
|
| Neoplasms | 2 | 2019 | 1667 | 0.150 |
Why?
|
| Neoplasm Metastasis | 2 | 2016 | 306 | 0.150 |
Why?
|
| Shoulder Joint | 1 | 2019 | 110 | 0.140 |
Why?
|
| Behavioral Risk Factor Surveillance System | 1 | 2017 | 73 | 0.140 |
Why?
|
| Catheter Ablation | 1 | 2019 | 229 | 0.140 |
Why?
|
| Accountable Care Organizations | 1 | 2016 | 7 | 0.140 |
Why?
|
| Utilization Review | 1 | 2016 | 48 | 0.140 |
Why?
|
| Pilot Projects | 2 | 2019 | 1342 | 0.140 |
Why?
|
| Tomography, X-Ray Computed | 3 | 2015 | 2324 | 0.130 |
Why?
|
| Physician's Role | 1 | 2017 | 116 | 0.130 |
Why?
|
| Patient-Centered Care | 1 | 2017 | 106 | 0.130 |
Why?
|
| Biomarkers, Tumor | 1 | 2019 | 508 | 0.130 |
Why?
|
| Socioeconomic Factors | 1 | 2018 | 955 | 0.130 |
Why?
|
| Health Resources | 1 | 2015 | 76 | 0.130 |
Why?
|
| Adipose Tissue | 1 | 2016 | 221 | 0.120 |
Why?
|
| Quality Improvement | 1 | 2019 | 413 | 0.120 |
Why?
|
| Incidental Findings | 1 | 2015 | 42 | 0.120 |
Why?
|
| Chemoradiotherapy | 1 | 2015 | 54 | 0.120 |
Why?
|
| Pneumonectomy | 1 | 2015 | 79 | 0.120 |
Why?
|
| Medicare | 1 | 2016 | 319 | 0.120 |
Why?
|
| Fear | 1 | 2015 | 239 | 0.120 |
Why?
|
| Diffusion Magnetic Resonance Imaging | 1 | 2016 | 239 | 0.120 |
Why?
|
| Emotions | 1 | 2015 | 244 | 0.110 |
Why?
|
| Clinical Competence | 1 | 2018 | 657 | 0.110 |
Why?
|
| Logistic Models | 1 | 2017 | 1420 | 0.110 |
Why?
|
| Pregnancy | 1 | 2019 | 2334 | 0.110 |
Why?
|
| Health Services Accessibility | 1 | 2017 | 581 | 0.100 |
Why?
|
| Anxiety | 1 | 2015 | 422 | 0.100 |
Why?
|
| Incidence | 1 | 2016 | 1603 | 0.100 |
Why?
|
| Practice Guidelines as Topic | 1 | 2016 | 772 | 0.100 |
Why?
|
| Health Care Costs | 1 | 2014 | 346 | 0.100 |
Why?
|
| Motivation | 1 | 2015 | 561 | 0.100 |
Why?
|
| Postoperative Complications | 1 | 2019 | 1615 | 0.090 |
Why?
|
| Cross-Sectional Studies | 1 | 2017 | 2279 | 0.090 |
Why?
|
| Prospective Studies | 1 | 2017 | 3705 | 0.080 |
Why?
|
| Superior Vena Cava Syndrome | 1 | 2009 | 15 | 0.080 |
Why?
|
| Scoliosis | 1 | 2009 | 42 | 0.080 |
Why?
|
| Radiotherapy, Adjuvant | 2 | 2020 | 125 | 0.080 |
Why?
|
| Spinal Fusion | 1 | 2009 | 90 | 0.080 |
Why?
|
| Time Factors | 1 | 2015 | 4655 | 0.070 |
Why?
|
| Hormone Replacement Therapy | 1 | 2005 | 20 | 0.060 |
Why?
|
| Carcinoma in Situ | 1 | 2005 | 47 | 0.060 |
Why?
|
| Carcinoma, Ductal, Breast | 1 | 2005 | 62 | 0.060 |
Why?
|
| Family Health | 1 | 2005 | 83 | 0.060 |
Why?
|
| Diagnostic Errors | 1 | 2005 | 100 | 0.060 |
Why?
|
| Adolescent | 2 | 2015 | 8912 | 0.060 |
Why?
|
| Data Interpretation, Statistical | 1 | 2003 | 329 | 0.050 |
Why?
|
| Computers | 1 | 2021 | 63 | 0.050 |
Why?
|
| Triage | 1 | 2021 | 109 | 0.040 |
Why?
|
| Disease-Free Survival | 1 | 2020 | 349 | 0.040 |
Why?
|
| Lymphatic Metastasis | 1 | 2020 | 274 | 0.040 |
Why?
|
| X-Rays | 1 | 2019 | 56 | 0.040 |
Why?
|
| Biopsy, Fine-Needle | 1 | 2019 | 76 | 0.040 |
Why?
|
| Kaplan-Meier Estimate | 1 | 2020 | 536 | 0.040 |
Why?
|
| Biopsy, Large-Core Needle | 1 | 2018 | 4 | 0.040 |
Why?
|
| Signal-To-Noise Ratio | 1 | 2018 | 93 | 0.040 |
Why?
|
| Radiology | 1 | 2019 | 97 | 0.040 |
Why?
|
| Carcinoma, Intraductal, Noninfiltrating | 1 | 2018 | 33 | 0.040 |
Why?
|
| Proportional Hazards Models | 1 | 2020 | 792 | 0.040 |
Why?
|
| Standard of Care | 1 | 2018 | 22 | 0.040 |
Why?
|
| Swine | 1 | 2019 | 672 | 0.040 |
Why?
|
| Neoplasm Recurrence, Local | 1 | 2020 | 446 | 0.040 |
Why?
|
| Promoter Regions, Genetic | 1 | 2019 | 615 | 0.040 |
Why?
|
| Radiographic Image Enhancement | 1 | 2018 | 208 | 0.040 |
Why?
|
| Male | 1 | 2019 | 37321 | 0.040 |
Why?
|
| Calcinosis | 1 | 2018 | 241 | 0.040 |
Why?
|
| Image Enhancement | 1 | 2016 | 143 | 0.030 |
Why?
|
| Neoadjuvant Therapy | 1 | 2015 | 104 | 0.030 |
Why?
|
| Triple Negative Breast Neoplasms | 1 | 2015 | 41 | 0.030 |
Why?
|
| Receptors, Estrogen | 1 | 2015 | 142 | 0.030 |
Why?
|
| Receptor, ErbB-2 | 1 | 2015 | 129 | 0.030 |
Why?
|
| Rats, Sprague-Dawley | 1 | 2019 | 2083 | 0.030 |
Why?
|
| Combined Modality Therapy | 1 | 2016 | 951 | 0.030 |
Why?
|
| Contrast Media | 1 | 2016 | 595 | 0.030 |
Why?
|
| Rats | 1 | 2019 | 5300 | 0.020 |
Why?
|
| Prone Position | 1 | 2009 | 8 | 0.020 |
Why?
|
| Treatment Outcome | 1 | 2016 | 7029 | 0.020 |
Why?
|
| Animals | 1 | 2019 | 20881 | 0.010 |
Why?
|